Neonc Technologies Holdings, Inc.
HealthcareNASDAQ:NTHI · NASDAQ Global Select
+$0.25 today
Vol 0.64M · Avg 0.07M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
355.0%
avg 355.0%
ROIC
519.7%
avg 519.7%
ROA
-2200.9%
avg -2200.9%
Analysis
ROIC is currently the strongest return metric at 519.7% versus its period average of 519.7%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Thomas C. Chen | Founder, Chief Medical Officer, Chief Scientific Officer & Vice Chairman | $212,000.00 | — | 61 | $551,668.00 | 2.76% |
Keithly A. Garnett | Chief Financial Officer | $179,000.00 | — | 51 | $240,900.00 | 1.20% |
Josh Neman-Ebrahim | Chief Clinical Officer | $165,000.00 | — | 48 | $134,260.00 | 0.67% |
Amir Farrokh Heshmatpour | President, Chief Executive Officer, Executive Chairman & Secretary | — | — | 59 | $2.99M | 14.96% |
David Choi | Chief Accounting Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
4
$192,019.00
Sells
0
$0.00
Net Sentiment
+$192,019.00
Net buying
Most Active
Heshmatpour Amir F
3 transactions
Analysis
Insiders reported 4 buys worth $192,019.00 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $192,019.00. Heshmatpour Amir F was the most active insider with 3 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +374.4% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Forward estimates point to Revenue at +374.4% (5yr), giving you a quick read on expected growth from here.
Competitors
Peer companies in the same sector
No competitor data available.
Who manages NTHI?
Neonc Technologies Holdings, Inc. (NTHI) lists 5 active executives. The top listed executive is Josh Neman-Ebrahim, Chief Clinical Officer.
Are NTHI insiders buying or selling?
Recent insider activity shows net selling of $3.42M.
Explore More
Continue the stock analysis
Jump to another research area for this company.